Pfizer beats earnings estimates months after stock dipped to record lows
[ad_1] Despite revenue declines, Pfizer’s first-quarter earnings released Wednesday beat investors’ expectations due to slower-than-expected declines in sales of its Covid-19 products and growth in
Read more